These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 29463286)
21. Prevention and therapy of bronchopulmonary dysplasia - evidence and clinical practice. Thomas W; Speer CP Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):264-77. PubMed ID: 17582275 [TBL] [Abstract][Full Text] [Related]
22. [From classic to new bronchopulmonary dysplasia]. Kramer BW; Lievense S; Been JV; Zimmermann LJ Ned Tijdschr Geneeskd; 2010; 154():A1024. PubMed ID: 20456770 [TBL] [Abstract][Full Text] [Related]
24. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial. Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774 [TBL] [Abstract][Full Text] [Related]
25. Bronchopulmonary dysplasia: what are its links to COPD? McGrath-Morrow SA; Collaco JM Ther Adv Respir Dis; 2019; 13():1753466619892492. PubMed ID: 31818194 [TBL] [Abstract][Full Text] [Related]
26. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants. Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631 [TBL] [Abstract][Full Text] [Related]
27. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression. Villamor-Martinez E; Álvarez-Fuente M; Ghazi AMT; Degraeuwe P; Zimmermann LJI; Kramer BW; Villamor E JAMA Netw Open; 2019 Nov; 2(11):e1914611. PubMed ID: 31693123 [TBL] [Abstract][Full Text] [Related]
28. Surfactant therapy guided by tests for lung maturity in preterm infants at risk of respiratory distress syndrome. Sibrecht G; Kearl CR; Borys F; Morariu M; Bruschettini M; Soll R Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013158. PubMed ID: 37882216 [TBL] [Abstract][Full Text] [Related]
29. Correlation between early postnatal body weight changes and lung ultrasound scores as predictors of bronchopulmonary dysplasia in preterm infants: A secondary analysis of a prospective study. Ghanem M; Zozaya C; Ibrahim J; Lee S; Mohsen N; Nasef N; Mohamed A Eur J Pediatr; 2024 May; 183(5):2123-2130. PubMed ID: 38363393 [TBL] [Abstract][Full Text] [Related]
30. Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study. van Katwyk S; Augustine S; Thébaud B; Thavorn K BMC Pediatr; 2020 Mar; 20(1):136. PubMed ID: 32213174 [TBL] [Abstract][Full Text] [Related]
31. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial. Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA; JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344 [TBL] [Abstract][Full Text] [Related]
32. Prevention of bronchopulmonary dysplasia: current strategies. Jain D; Bancalari E Zhongguo Dang Dai Er Ke Za Zhi; 2017 Aug; 19(8):841-851. PubMed ID: 28774356 [TBL] [Abstract][Full Text] [Related]
33. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome. Abdel-Latif ME; Walker E; Osborn DA Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182 [TBL] [Abstract][Full Text] [Related]
34. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Onland W; Offringa M; van Kaam A Cochrane Database Syst Rev; 2017 Aug; 8(8):CD002311. PubMed ID: 28836266 [TBL] [Abstract][Full Text] [Related]
35. Recent Advances in Bronchopulmonary Dysplasia. Shukla VV; Ambalavanan N Indian J Pediatr; 2021 Jul; 88(7):690-695. PubMed ID: 34018135 [TBL] [Abstract][Full Text] [Related]
36. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229 [TBL] [Abstract][Full Text] [Related]
37. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia. Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276 [TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of bronchopulmonary dysplasia in very preterm infants. Yang Y; He X; Zhang X; Chen P Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1592-1601. PubMed ID: 38432888 [TBL] [Abstract][Full Text] [Related]
40. [Lung Function in Childhood and Adolescence: Influence of Prematurity and Bronchopulmonary Dysplasia]. Segerer FJ; Speer CP Z Geburtshilfe Neonatol; 2016 Aug; 220(4):147-54. PubMed ID: 27104655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]